Physician profile
Natalie B Geier
NPI 1851735252
$338.37
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $55.61 · 2022: $136 · 2023: $126 · 2024: $20.19.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $146.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $42.19 | 2022-2023 | Flexitouch Plus, Entre Plus |
| Tersera Therapeutics LLC | $40.04 | 2022-2024 | Zoladex |
| Janssen Biotech, INC. | $33.92 | 2019-2023 | Imbruvica |
| Bayer Healthcare Pharmaceuticals INC. | $29.78 | 2022-2023 | |
| Gilead Sciences, INC. | $27.11 | 2022 | |
| Novartis Pharmaceuticals Corporation | $24.55 | 2023 | |
| Sun Pharmaceutical Industries INC. | $22.46 | 2023 | Odomzo, Yonsa |
| Merck Sharp & Dohme LLC | $19.54 | 2022 | |
| Janssen Pharmaceuticals, INC | $15.07 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $14.95 | 2022 | |
| Jazz Pharmaceuticals INC. | $14.77 | 2022 | |
| Pharmacyclics LLC, An Abbvie Company | $14.25 | 2019 | |
| Siemens Medical Solutions USA, INC. | $13.94 | 2023 | Somatom Go.Top |
| Genentech USA, INC. | $13.62 | 2023 | Phesgo |
| Puma Biotechnology, INC. | $12.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Natalie Geier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.